Kent Thoelke

For Kent Thoelke, the job of PRA Health Sciences Inc (NASDAQ: PRAH)’s chief scientific officer is part drug development, part social media management. The disparate responsibilities seem to have disparate aims, but PRA swears that patient engagement is critical to pharmaceutical pipelines....